IL33 and diabetic kidney disease: Hofherr et al. found elevated renal IL-33 expression in DKD patients and demonstrated that the inhibition of IL-33 signaling alleviated kidney inflammation and fibrosis in diabetic mice, suggesting a pathogenic role in this context.